Evidence map›Paper›PMID 38330312›Full record

ArticleThe Journal of infectious diseases2024

Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants.

Rachel M Burke, Daniel C Payne, Monica McNeal, Shannon C Conrey, Allison R Burrell, Claire P Mattison, Mary C Casey-Moore, Slavica Mijatovic-Rustempasic, Rashi Gautam, Mathew D Esona and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rachel M BurkeDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0002-5678-5826
Daniel C PayneDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Monica McNealDepartment of Pediatrics, University of Cincinnati College of Medicine.
Shannon C ConreyDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center.
Allison R BurrellDepartment of Pediatrics, University of Cincinnati College of Medicine.
Claire P MattisonDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mary C Casey-MooreDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Slavica Mijatovic-RustempasicDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Rashi GautamDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mathew D EsonaDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alexander W ThormanDepartment of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Michael D BowenDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Umesh D ParasharDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jacqueline E TateDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ardythe L MorrowDepartment of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Mary A StaatDepartment of Pediatrics, University of Cincinnati College of Medicine.
Centers for Disease Control and Prevention · USCincinnati Children's Hospital Medical Center · USCincinnati Health Department · US

Funding

Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza ImmunityU01AI144673 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI STAAT, MARY A · 2019 to 2025
$36.4M
Molecular Epidemiology in Children's Environmental Health Training Program (MECEH)T32ES010957 · NIEHS · UNIVERSITY OF CINCINNATI · PI Kelly J Brunst · 2001 to 2026
$11.1M
Intramural CDC HHS CC999999NCIRD CDC HHS U01 IP001059NIAID NIH HHS U01 AI144673NIEHS NIH HHS T32 ES010957PREVAILUS Centers for Disease Control and Prevention IP16-004
6 · The paper itself

Abstract

backgroundRotavirus is a leading cause of severe pediatric gastroenteritis; 2 highly effective vaccines are used in the United States (US). We aimed to identify correlates of immune response to rotavirus vaccination in a US cohort.

methodsPediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal (PREVAIL) is a birth cohort of 245 mother-child pairs enrolled in 2017-2018 and followed for 2 years. Infant stool samples and symptom information were collected weekly. Shedding was defined as reverse-transcription polymerase chain reaction detection of rotavirus vaccine virus in stools collected 4-28 days after dose 1. Seroconversion was defined as a 3-fold rise in immunoglobulin A between the 6-week and 6-month blood draws. Correlates were analyzed using generalized estimating equations and logistic regression.

resultsPrevaccination immunoglobulin G (IgG) (odds ratio [OR], 0.84 [95% confidence interval {CI}, .75-.94] per 100-unit increase) was negatively associated with shedding. Shedding was also less likely among infants with a single-nucleotide polymorphism inactivating FUT2 antigen secretion ("nonsecretors") with nonsecretor mothers, versus all other combinations (OR, 0.37 [95% CI, .16-.83]). Of 141 infants with data, 105 (74%) seroconverted; 78 (77%) had shed vaccine virus following dose 1. Prevaccination IgG and secretor status were significantly associated with seroconversion. Neither shedding nor seroconversion significantly differed by vaccine product.

conclusionsIn this US cohort, prevaccination IgG and maternal and infant secretor status were associated with rotavirus vaccine response.

Indexed as

Antibodies, ViralFecesImmunoglobulin GRotavirusRotavirus InfectionsRotavirus VaccinesSeroconversionVirus SheddingAdultBirth CohortCohort StudiesFemaleHumansImmunoglobulin AInfantLongitudinal StudiesAntibodies, ViralImmunoglobulin AImmunoglobulin GRotavirus Vaccineshisto-blood group antigens (HBGA)pediatric gastroenteritisrotavirusrotavirus vaccinevaccine immunogenicityvaccine responsevaccine shedding

Identifiers

PMID38330312
PMCPMC12093357
OpenAlexW4391636678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.